Global Depression Treatment Therapy Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 102

Report ID: 3719

Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest.
One of the major factors for such low growth is a rapid decline in the revenue of branded drug manufacturers and growing strength of generic drug manufacturers. The introduction of virtual reality in the treatment of disorders such as post-traumatic stress disorders is also driving the market.
In 2018, the global Depression Treatment Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Depression Treatment Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Depression Treatment Therapy development in United States, Europe and China.

The key players covered in this study
Pfizer
Teva Pharmaceutical
Johnson and Johnson
Merck
Eli Lily
Novartis
Sanofi
AstraZeneca
Allergan
Mayo Clinic
Bristol-Myers Squibb
Takeda
Brainsway
Lundbeck
NeuroStar
Otsuka
VistaGen Therapeutics
Silver Oak Health
NeuroSigma

Market segment by Type, the product can be split into
Drugs
Treatment device

Market segment by Application, split into
Seasonal affective disorder (SAD)
Major depression
Dysthymia disorder
Postpartum depression
Atypical depression
Psychotic depression
Bipolar disorder

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Depression Treatment Therapy status, future forecast, growth opportunity, key market and key players.
To present the Depression Treatment Therapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Depression Treatment Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Depression Treatment Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Drugs
1.4.3 Treatment device
1.5 Market by Application
1.5.1 Global Depression Treatment Therapy Market Share by Application (2014-2025)
1.5.2 Seasonal affective disorder (SAD)
1.5.3 Major depression
1.5.4 Dysthymia disorder
1.5.5 Postpartum depression
1.5.6 Atypical depression
1.5.7 Psychotic depression
1.5.8 Bipolar disorder
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Depression Treatment Therapy Market Size
2.2 Depression Treatment Therapy Growth Trends by Regions
2.2.1 Depression Treatment Therapy Market Size by Regions (2014-2025)
2.2.2 Depression Treatment Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Depression Treatment Therapy Market Size by Manufacturers
3.1.1 Global Depression Treatment Therapy Revenue by Manufacturers (2014-2019)
3.1.2 Global Depression Treatment Therapy Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Depression Treatment Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Depression Treatment Therapy Key Players Head office and Area Served
3.3 Key Players Depression Treatment Therapy Product/Solution/Service
3.4 Date of Enter into Depression Treatment Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Depression Treatment Therapy Market Size by Type (2014-2019)
4.2 Global Depression Treatment Therapy Market Size by Application (2014-2019)

5 United States
5.1 United States Depression Treatment Therapy Market Size (2014-2019)
5.2 Depression Treatment Therapy Key Players in United States
5.3 United States Depression Treatment Therapy Market Size by Type
5.4 United States Depression Treatment Therapy Market Size by Application

6 Europe
6.1 Europe Depression Treatment Therapy Market Size (2014-2019)
6.2 Depression Treatment Therapy Key Players in Europe
6.3 Europe Depression Treatment Therapy Market Size by Type
6.4 Europe Depression Treatment Therapy Market Size by Application

7 China
7.1 China Depression Treatment Therapy Market Size (2014-2019)
7.2 Depression Treatment Therapy Key Players in China
7.3 China Depression Treatment Therapy Market Size by Type
7.4 China Depression Treatment Therapy Market Size by Application

8 Japan
8.1 Japan Depression Treatment Therapy Market Size (2014-2019)
8.2 Depression Treatment Therapy Key Players in Japan
8.3 Japan Depression Treatment Therapy Market Size by Type
8.4 Japan Depression Treatment Therapy Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Depression Treatment Therapy Market Size (2014-2019)
9.2 Depression Treatment Therapy Key Players in Southeast Asia
9.3 Southeast Asia Depression Treatment Therapy Market Size by Type
9.4 Southeast Asia Depression Treatment Therapy Market Size by Application

10 India
10.1 India Depression Treatment Therapy Market Size (2014-2019)
10.2 Depression Treatment Therapy Key Players in India
10.3 India Depression Treatment Therapy Market Size by Type
10.4 India Depression Treatment Therapy Market Size by Application

11 Central & South America
11.1 Central & South America Depression Treatment Therapy Market Size (2014-2019)
11.2 Depression Treatment Therapy Key Players in Central & South America
11.3 Central & South America Depression Treatment Therapy Market Size by Type
11.4 Central & South America Depression Treatment Therapy Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Depression Treatment Therapy Introduction
12.1.4 Pfizer Revenue in Depression Treatment Therapy Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Teva Pharmaceutical
12.2.1 Teva Pharmaceutical Company Details
12.2.2 Company Description and Business Overview
12.2.3 Depression Treatment Therapy Introduction
12.2.4 Teva Pharmaceutical Revenue in Depression Treatment Therapy Business (2014-2019)
12.2.5 Teva Pharmaceutical Recent Development
12.3 Johnson and Johnson
12.3.1 Johnson and Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Depression Treatment Therapy Introduction
12.3.4 Johnson and Johnson Revenue in Depression Treatment Therapy Business (2014-2019)
12.3.5 Johnson and Johnson Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Depression Treatment Therapy Introduction
12.4.4 Merck Revenue in Depression Treatment Therapy Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Eli Lily
12.5.1 Eli Lily Company Details
12.5.2 Company Description and Business Overview
12.5.3 Depression Treatment Therapy Introduction
12.5.4 Eli Lily Revenue in Depression Treatment Therapy Business (2014-2019)
12.5.5 Eli Lily Recent Development
12.6 Novartis
12.6.1 Novartis Company Details
12.6.2 Company Description and Business Overview
12.6.3 Depression Treatment Therapy Introduction
12.6.4 Novartis Revenue in Depression Treatment Therapy Business (2014-2019)
12.6.5 Novartis Recent Development
12.7 Sanofi
12.7.1 Sanofi Company Details
12.7.2 Company Description and Business Overview
12.7.3 Depression Treatment Therapy Introduction
12.7.4 Sanofi Revenue in Depression Treatment Therapy Business (2014-2019)
12.7.5 Sanofi Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Company Details
12.8.2 Company Description and Business Overview
12.8.3 Depression Treatment Therapy Introduction
12.8.4 AstraZeneca Revenue in Depression Treatment Therapy Business (2014-2019)
12.8.5 AstraZeneca Recent Development
12.9 Allergan
12.9.1 Allergan Company Details
12.9.2 Company Description and Business Overview
12.9.3 Depression Treatment Therapy Introduction
12.9.4 Allergan Revenue in Depression Treatment Therapy Business (2014-2019)
12.9.5 Allergan Recent Development
12.10 Mayo Clinic
12.10.1 Mayo Clinic Company Details
12.10.2 Company Description and Business Overview
12.10.3 Depression Treatment Therapy Introduction
12.10.4 Mayo Clinic Revenue in Depression Treatment Therapy Business (2014-2019)
12.10.5 Mayo Clinic Recent Development
12.11 Bristol-Myers Squibb
12.12 Takeda
12.13 Brainsway
12.14 Lundbeck
12.15 NeuroStar
12.16 Otsuka
12.17 VistaGen Therapeutics
12.18 Silver Oak Health
12.19 NeuroSigma

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details